<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
Under the Securities Exchange Act of 1934
(Amendment No.: 0 )*
Name of issuer: Targeted Genetics
Title of Class of Securities: Common Stock
CUSIP Number: 87612M108
Check the following [space] if a fee is being paid with this
statement: N/A . (A fee is not required only if the filing person:
(1) has a previous statement on file reporting beneficial ownership
of more than five percent of the class of securities described in
Item 1; and (2) has filed no amendment subsequent thereto reporting
beneficial ownership of five percent or less of such class.) (See
rule 13d-7.)
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
(Continued on the following page(s))
Page 1 of 4 Pages
<PAGE> 2
13G
CUSIP No.: 87612M108 Page 2 of 4 Pages
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Vanguard Specialized Portfolios - Health Care Portfolio
2. CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP
A. B. X
----------
3. SEC USE ONLY
4. CITIZENSHIP OF PLACE OF ORGANIZATION
Maryland
(For questions 5-8, report the number of shares beneficially owned by each
reporting person with:)
5. SOLE VOTING POWER
1,224,600
6. SHARED VOTING POWER
-0-
7. SOLE DISPOSITIVE POWER
-0-
8. SHARED DISPOSITIVE POWER
1,224,600
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,224,600
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
N/A
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.09
12. TYPE OF REPORTING PERSON
IV
<PAGE> 3
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------
SCHEDULE 13G
Under the Securities Act of 1934
----------
Check the following [line] if a fee is being paid with this statement N/A
Item 1(a) - Name of Issuer:
Targeted Genetics
Item 1(b) - Address of Issuer's Principal Executive Offices:
1100 Olive Way, Seattle, WA 98101
Item 2(a) - Name of Person Filing:
Vanguard Specialized Portfolios - Health Care
Portfolio
Item 2(b) - Title of Class of Securities:
Common Stock
Item 2(e) - CUSIP Number
87612M108
Item 3 - Type of Filing:
This statement is being filed pursuant to Rule 13d-1. The person
filing is an investment company registered under Section 8 of the Investment
Company Act.
Item 4 - Ownership:
(a) Amount Beneficially Owned:
1,224,600
(b) Percent of Class:
6.09
Page 3 of 4 Pages
<PAGE> 4
(c) Number of shares as to which such person has:
(i) sole power to vote or direct to vote: 1,224,600
(ii) shared power to vote or direct to vote: -0-
(iii) sole power to dispose of or to direct the disposition of:
-0-
(iv) shared power to dispose or to direct the disposition of:
1,224,600
Item 5 - Ownership of Five Percent or Less of a Class:
Not applicable
Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:
Not applicable
Item 7 - Identification and Classification of the Subsidiary Which Acquired The
Security Being Reported on by the Parent Holding Company:
Not applicable
Item 8 - Identification and Classification of Members of Group:
Not applicable
Item 9 - Notice of Dissolution of Group:
Not applicable
Item 10 - Certification:
By signing below I certify than, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course
of business and were not acquired for the purpose of and do not have the effect
of changing or influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in any transaction
having such purpose or effect.
Signature
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Date 2-4-97 By /s/ Raymond J. Klapinsky
----------------- -----------------------------
Raymond J. Klapinsky
Page 4 of 4 Pages
